Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region
(352) 733-0111

All results

2 results for randomized double blind multiple dose placebo controlled study evaluate safety 0

  • ATYR

    This randomized, double-blind, placebo matched to efzofitimod-controlled, study will evaluate the safety, tolerability, immunogenicity, pharmacokinetic (PK),…

    Ages
    18 Years - 75 Years
    Sexes
    All
  • ALXN2050-NEPH-201

    This is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study of ALXN2050 (120 and 180 milligrams [mg]) in addition to background therapy…

    Ages
    18 Years - 75 Years
    Sexes
    All